Implanet received FDA clearance from U.S. and European regulatory authorities to market its updated JAZZ braid.
Here are five key points:
1. This redesigned JAZZ braid comes in response to surgeon feedback since the original launch in 2013.
2. Technical characteristics have been improved, with part of the band now ultrasonically bonded. The braid will also continue to interface with the proprietary JAZZ tensioning system.
3. The new braid focuses on technological improvements to simply surgical procedures and facilitates the use of JAZZ in new surgical indications.
4. This is the 10th Implanet JAZZ product to receive FDA approval.
5. Implanet is a medical technology company specializing in vertebral and knee surgery implants.